Significant expression changes of four LGZG-regulated genes (OSGIN1, AHR, IRF2BP2, and RASGEF1B) exhibited alleviation of oxidative stress upon LGZG treatment, compared with the NAFLD group. The gene discussed is IRF2BP2; the disease is metabolic dysfunction-associated steatotic liver disease.